SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-18-030346
Filing Date
2018-05-04
Accepted
2018-05-03 18:55:24
Documents
53
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a18-8662_110q.htm 10-Q 865249
2 EX-10.80 a18-8662_1ex10d80.htm EX-10.80 40718
3 EX-31 a18-8662_1ex31.htm EX-31 9934
4 EX-32 a18-8662_1ex32.htm EX-32 6322
11 GRAPHIC g86621kgi001.jpg GRAPHIC 6462
12 GRAPHIC g86621kgi002.jpg GRAPHIC 3444
  Complete submission text file 0001104659-18-030346.txt   4391227

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT inva-20180331.xml EX-101.INS 998745
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT inva-20180331.xsd EX-101.SCH 40105
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT inva-20180331_cal.xml EX-101.CAL 57988
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT inva-20180331_def.xml EX-101.DEF 136439
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT inva-20180331_lab.xml EX-101.LAB 343849
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT inva-20180331_pre.xml EX-101.PRE 243172
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 18805527
SIC: 2834 Pharmaceutical Preparations